During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, Klugmann M, Banks WA, Drucker DJ, Haile CN (2003) Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
In general, prior authorization can be obtained for some of the GLP-1 agonists if you and your healthcare provider can prove they are medically necessary and you meet certain criteria
That said, monitor for any mood changes, especially in patients with pre-existing psychiatric conditions, and adjust psychiatric medications as weight changes (some psych med levels can be affected by significant weight loss)
Prioritizing protein prevents muscle loss, ensuring that weight lost comes primarily from fat stores